What is the effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels?
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels was studied by Sacks et al. (1996), and the results showed that pravastatin reduced the risk of recurrent coronary events, such as nonfatal myocardial infarction, unstable angina, and coronary revascularization, compared to placebo. Additionally, pravastatin lowered the risk of all-cause mortality, cardiac mortality, and stroke. The study concluded that pravastatin is effective for the primary prevention of cardiovascular disease in patients with average cholesterol levels.